Search for other papers by Waleed K W Al-Badri in
Google Scholar
PubMed
Search for other papers by Hinke Marijke Jellema in
Google Scholar
PubMed
Search for other papers by Arnaud R G G Potvin in
Google Scholar
PubMed
Search for other papers by Ruth M A van Nispen in
Google Scholar
PubMed
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Search for other papers by Peerooz Saeed in
Google Scholar
PubMed
Introduction Graves’ ophthalmopathy (GO) is an autoimmune disease characterized by the inflammation of the periorbital tissues. Inflammation in GO may result in dry eyes, erythema, periorbital swelling, exophthalmos, conjunctivitis, upper
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by B Shahida in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Malmö, Sweden
Search for other papers by P Sahlstrand Johnson in
Google Scholar
PubMed
Search for other papers by R Jain in
Google Scholar
PubMed
Department of Plastic Surgery, Skåne University Hospital, Malmö, Sweden
Search for other papers by H Brorson in
Google Scholar
PubMed
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by P Åsman in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by M Lantz in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by T Planck in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease is a prerequisite for the development of Graves’ ophthalmopathy (GO), and both thyroid and orbital tissues are infiltrated by immunocompetent cells. The thyroid-stimulating hormone receptor (TSHR) acts
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Bushra Shahida in
Google Scholar
PubMed
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Search for other papers by Tania Singh in
Google Scholar
PubMed
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
Introduction Graves’ disease (GD) and Graves’ ophthalmopathy (GO) are both complex autoimmune diseases that are caused by an interplay of environmental factors and genetic susceptibility ( 1 ). Risk factors such as smoking, emotional stress
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
JJ Sullivan TJ Mortimer RH Wagenaar M Perry-Keene DA . Assessing quality of life in Australian patients with Graves’ ophthalmopathy . British Journal of Ophthalmology 2004 88 75 – 78 . ( https://doi.org/10.1136/bjo.88.1.75 ) 6 Wickwar S
Department of Endocrinology, The People’s Hospital of Daxing District, Beijing, China
Search for other papers by Ya-Fen Hu in
Google Scholar
PubMed
Search for other papers by Lin Hua in
Google Scholar
PubMed
Search for other papers by Xiu Tuo in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Yi-Lin Yang in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong-Yu Yan in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Ophthalmology 2014 2014 435276 . 25101183 9 Nagy EV Toth J Kaldi I Damjanovich J Mezosi E Lenkey A Toth L Szabo J Karanyi Z Leovey A . Graves’ ophthalmopathy: eye muscle involvement in patients with diplopia . European Journal of
Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
. ( https://doi.org/10.1530/EJE-21-0479 ) 3 Mourits MP Koornneef L Wiersinga WM Prummel MF Berghout A van der Gaag R . Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach . British Journal of
Search for other papers by Jakub Supronik in
Google Scholar
PubMed
Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
Search for other papers by Adam Kretowski in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
’ ophthalmopathy . New England Journal of Medicine 2010 362 726 – 738 . ( https://doi.org/10.1056/NEJMra0905750 ) 2 Hiromatsu Y Eguchi H Tani J Kasaoka M Teshima Y . Graves’ ophthalmopathy: epidemiology and natural history . Internal Medicine 2014 53
Search for other papers by Yue-Yue Wang in
Google Scholar
PubMed
Search for other papers by Qian Wu in
Google Scholar
PubMed
Search for other papers by Lu Chen in
Google Scholar
PubMed
Search for other papers by Wen Chen in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
Search for other papers by Xiao-Quan Xu in
Google Scholar
PubMed
Search for other papers by Fei-Yun Wu in
Google Scholar
PubMed
Search for other papers by Hao Hu in
Google Scholar
PubMed
Search for other papers by Huan-Huan Chen in
Google Scholar
PubMed
Foundation to Huan-Huan Chen. References 1 Bahn RS Graves’ ophthalmopathy . New England Journal of Medicine 2010 362 726 – 738 . ( https://doi.org/10.1056/NEJMra0905750 ) 2 Bartalena L Baldeschi L Boboridis K Eckstein A Kahaly
Search for other papers by Qing Zhu in
Google Scholar
PubMed
Search for other papers by Jianbin Su in
Google Scholar
PubMed
Search for other papers by Xueqin Wang in
Google Scholar
PubMed
Search for other papers by Mengjie Tang in
Google Scholar
PubMed
Search for other papers by Yingying Gao in
Google Scholar
PubMed
Search for other papers by Dongmei Zhang in
Google Scholar
PubMed
Patients A total of 72 GD patients without Graves’ ophthalmopathy (52 females and 20 males, mean age 41 ± 11 years) were recruited for this study at the Nantong City No 1 People’s Hospital and Second Affiliated Hospital of Nantong University between June
Search for other papers by Xichang Wang in
Google Scholar
PubMed
Search for other papers by Xiaochun Teng in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Jing Li in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Yaxin Lai in
Google Scholar
PubMed
the references from the initially included studies was also performed to identify eligible studies. Several specific studies on GO (Graves’ ophthalmopathy) or relapsing GD were excluded. Questionnaire design and survey implementation Previously